ANI Pharmaceuticals/ US00182C1036 /
7/26/2024 9:59:56 PM | Chg. +1.30 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
63.23USD | +2.10% | 6,791 Turnover: 424,291.75 |
-Bid Size: - | -Ask Size: - | 1.33 bill.USD | - | 73.55 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 0.86 USD | - |
EPS Diluted: | 0.85 USD | - |
Revenues per Share: | 23.11 USD | 27.76% |
Book Value per Share: | 20.54 USD | 14.55% |
Cash Flow per Share: | 5.65 USD | - |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 486.82 USD | - |
Net Income: | 17.15 USD | - |
Operating Cash Flow: | 118.96 USD | - |
Cash and Cash Equivalents: | 221.12 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 73.55 | 64.12 |
P/S Ratio: | 2.74 | 2.39 |
P/BV ratio: | 3.08 | 2.68 |
P/CF Ratio: | 11.20 | 9.77 |
PEG: | - | - |
Earnings Yield: | 1.36% | 1.56% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 1.33 bill. USD | 1.16 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 20.96 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | - |
Net Profit Margin: | - |
Return on Equity: | - |
Return on Assets: | - |
Financial Strength
Liquidity I / Cash Ratio: | - |
Liquidity II / Quick Ratio: | - |
Liquidity III / Current Ratio: | - |
Debt / Equity Ratio: | - |
Dynam. Debt / Equity Ratio: | - |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |